Lv1
50 积分 2024-01-15 加入
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
6天前
已完结
Critical Considerations of mRNA-LNPs Technology for CAR-T Therapy: Components, Payloads and Emerging Horizons
6天前
已完结
CAR T-cell therapy in autoimmune diseases
13天前
已完结
Trends in rare disease drug development
1个月前
已完结
Chimeric antigen receptor T cell therapy for autoimmune disease
3个月前
已完结
Estimating a Drug’s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold
3个月前
已完结
Estimating a Drug’s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold
3个月前
已关闭
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
3个月前
已关闭
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
3个月前
已关闭
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
3个月前
已完结
皖公网安备34019202002308
